Efficacy and safety of rolapitant for the prevention of chemotherapy-induced nausea and vomiting in subjects receiving highly emetogenic chemotherapy

Authors
Category Primary study
ConferenceSupportive Care in Cancer
Year 2012
This article has no abstract
Epistemonikos ID: a0791fe37b99317de9026b225529c349b5a4138f
First added on: Apr 30, 2026